Seth Rajeev K, Stoessel Kathleen M, Adelman Ron A
Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT 06520, USA.
Semin Ophthalmol. 2007 Apr-Jun;22(2):81-4. doi: 10.1080/08820530701418375.
A case of late-onset choroidal neovascularization in a patient with a history of West Nile virus chorioretinitis is described. An 86-year-old man with a history of diabetes mellitus developed bilateral West Nile virus chorioretinitis in 2001, after which his vision improved to baseline. Approximately 5 years later, the patient was found to have choroidal neovascularization in his left eye, for which he received an intravitreal injection of bevacizumab. After one injection, there was good anatomical response. Choroidal neovascularization may be a late-onset complication of West Nile virus chorioretinitis, and bevacizumab may be a good therapeutic option.
本文描述了一例有西尼罗河病毒脉络膜视网膜炎病史的患者发生迟发性脉络膜新生血管的病例。一名86岁有糖尿病病史的男性在2001年发生双侧西尼罗河病毒脉络膜视网膜炎，之后视力恢复到基线水平。大约5年后，该患者左眼被发现有脉络膜新生血管，为此他接受了玻璃体内注射贝伐单抗治疗。注射一次后，获得了良好的解剖学反应。脉络膜新生血管可能是西尼罗河病毒脉络膜视网膜炎的迟发性并发症，贝伐单抗可能是一种良好的治疗选择。
